PHARMATECA » Search Articles by Keyword
Found: 7 articles
| Article |
Edition |
|
Shatalova N.A., Mirzaev K.B., Abdullaev Sh.P., Sozaeva Zh.A., Bochkov P.O., Asoskova A.V., Denisenko N.P., Kochetkov A.I., Ebzeeva E.Yu., Chernyaeva M.S., Shastina V.R., Ostroumova O.D., Sychev D.A.
On the possible relationship between the presence of polymorphic variants of CYP3A4/5 cytochrome genes, their metabolic activity with rivaroxaban pharmacokinetics and the development of bleeding in patients with non-valvular atrial fibrillation and chronic kidney disease
|
№1 / 2024
|
|
M.G. Glezer
NEW ORAL ANTICOAGULANTS IN THE PREVENTION OF VENOUS THROMBOSIS AND THROMBOEMBOLISM: FOCUS ON RIVAROXABAN
|
№13 / 2014
|
|
T.E. Morozova, T.B. Andruschishina
PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION
|
№9 / 2014
|
|
G.A.Baryshnikova
MODERN POSSIBILITIES OF STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION
|
№6 / 2014
|
|
Ya.I. Ashikhmin (1), D.Yu.Schekochikhin (2)
INDIVIDUALIZED ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION
|
№18 / 2013
|
|
A.A. Kardanov, E. Yonuzi, A.P. Afanasiev, D.O. Ilyin, M.N. Maisigov
INTEGRATED MANAGEMENT OF SEVERE KNEE VALGUS USING SEMI-COMBINED IMPLANTS AND RIVAROXABAN
|
№10 / 2013
|
|
I.V.Zotova, D.A.Zateyshchikov
XA FACTOR INHIBITOR RIVAROXABAN IN ATRIAL FIBRILLATION
|
№9 / 2013
|
{"loading":"Loading...","close":"Close","yes":"Yes","no":"No","proceed":"Proceed","conf_del":"Do you really want to delete","cancel":"Cancel"}
Русский
